PROX1 is a predictor of survival for gliomas WHO grade II

The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers that can predict prognosis in individual patients is of great clinical value. PROX1 is a tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Elsir, Tamador (Author) , Qu, M. (Author) , Berntsson, S. G. (Author) , Orrego, A. (Author) , Olofsson, T. (Author) , Lindström, M. S. (Author) , Nistér, M. (Author) , Deimling, Andreas von (Author) , Hartmann, Christian (Author) , Ribom, D. (Author) , Smits, A. (Author)
Format: Article (Journal)
Language:English
Published: 10 May 2011
In: British journal of cancer
Year: 2011, Volume: 104, Issue: 11, Pages: 1747-1754
ISSN:1532-1827
DOI:10.1038/bjc.2011.162
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/bjc.2011.162
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/bjc2011162
Get full text
Author Notes:T. Elsir, M. Qu, S.G. Berntsson, A. Orrego, T. Olofsson, M.S. Lindström, M. Nistér, A. von Deimling, C. Hartmann, D. Ribom and A. Smits

MARC

LEADER 00000caa a2200000 c 4500
001 1800495706
003 DE-627
005 20220820172554.0
007 cr uuu---uuuuu
008 220428s2011 xx |||||o 00| ||eng c
024 7 |a 10.1038/bjc.2011.162  |2 doi 
035 |a (DE-627)1800495706 
035 |a (DE-599)KXP1800495706 
035 |a (OCoLC)1341459064 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Elsir, Tamador  |e VerfasserIn  |0 (DE-588)1256382787  |0 (DE-627)1800496397  |4 aut 
245 1 0 |a PROX1 is a predictor of survival for gliomas WHO grade II  |c T. Elsir, M. Qu, S.G. Berntsson, A. Orrego, T. Olofsson, M.S. Lindström, M. Nistér, A. von Deimling, C. Hartmann, D. Ribom and A. Smits 
264 1 |c 10 May 2011 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.04.2022 
520 |a The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers that can predict prognosis in individual patients is of great clinical value. PROX1 is a transcription factor that has a critical role in the development of various organs. PROX1 has been ascribed both oncogenic and tumour suppressive functions in human cancers. We have recently shown that PROX1 may act as a diagnostic marker for high-grade gliomas. The aim of this study was to address the prognostic value of PROX1 in grade II gliomas. 
650 4 |a CNS cancer 
650 4 |a Prognostic markers 
700 1 |a Qu, M.  |e VerfasserIn  |4 aut 
700 1 |a Berntsson, S. G.  |e VerfasserIn  |4 aut 
700 1 |a Orrego, A.  |e VerfasserIn  |4 aut 
700 1 |a Olofsson, T.  |e VerfasserIn  |4 aut 
700 1 |a Lindström, M. S.  |e VerfasserIn  |4 aut 
700 1 |a Nistér, M.  |e VerfasserIn  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Hartmann, Christian  |e VerfasserIn  |0 (DE-588)1030180539  |0 (DE-627)734895240  |0 (DE-576)377991465  |4 aut 
700 1 |a Ribom, D.  |e VerfasserIn  |4 aut 
700 1 |a Smits, A.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t British journal of cancer  |d Edinburgh : Nature Publ. Group, 1947  |g 104(2011), 11, Seite 1747-1754  |h Online-Ressource  |w (DE-627)320420094  |w (DE-600)2002452-6  |w (DE-576)103746854  |x 1532-1827  |7 nnas  |a PROX1 is a predictor of survival for gliomas WHO grade II 
773 1 8 |g volume:104  |g year:2011  |g number:11  |g pages:1747-1754  |g extent:8  |a PROX1 is a predictor of survival for gliomas WHO grade II 
856 4 0 |u https://doi.org/10.1038/bjc.2011.162  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/bjc2011162  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220428 
993 |a Article 
994 |a 2011 
998 |g 1030180539  |a Hartmann, Christian  |m 1030180539:Hartmann, Christian  |d 50000  |e 50000PH1030180539  |k 0/50000/  |p 9 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 8 
999 |a KXP-PPN1800495706  |e 4125266794 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1800495706"],"doi":["10.1038/bjc.2011.162"]},"note":["Gesehen am 28.04.2022"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"aut","display":"Elsir, Tamador","given":"Tamador","family":"Elsir"},{"given":"M.","family":"Qu","display":"Qu, M.","role":"aut"},{"role":"aut","display":"Berntsson, S. G.","given":"S. G.","family":"Berntsson"},{"family":"Orrego","given":"A.","role":"aut","display":"Orrego, A."},{"display":"Olofsson, T.","role":"aut","family":"Olofsson","given":"T."},{"role":"aut","display":"Lindström, M. S.","given":"M. S.","family":"Lindström"},{"given":"M.","family":"Nistér","display":"Nistér, M.","role":"aut"},{"family":"Deimling","given":"Andreas von","role":"aut","display":"Deimling, Andreas von"},{"display":"Hartmann, Christian","role":"aut","given":"Christian","family":"Hartmann"},{"given":"D.","family":"Ribom","role":"aut","display":"Ribom, D."},{"role":"aut","display":"Smits, A.","family":"Smits","given":"A."}],"title":[{"title":"PROX1 is a predictor of survival for gliomas WHO grade II","title_sort":"PROX1 is a predictor of survival for gliomas WHO grade II"}],"recId":"1800495706","physDesc":[{"extent":"8 S."}],"relHost":[{"recId":"320420094","origin":[{"dateIssuedKey":"1947","publisher":"Nature Publ. Group ; Churchill Livingstone","dateIssuedDisp":"1947-","publisherPlace":"Edinburgh ; Edinburgh"}],"part":{"extent":"8","pages":"1747-1754","volume":"104","issue":"11","text":"104(2011), 11, Seite 1747-1754","year":"2011"},"note":["Gesehen am 27.10.25"],"titleAlt":[{"title":"BJC"}],"title":[{"title_sort":"British journal of cancer","title":"British journal of cancer","subtitle":"BJC"}],"pubHistory":["Volume 1, issue 1 (1 March 1947)-"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"PROX1 is a predictor of survival for gliomas WHO grade IIBritish journal of cancer","id":{"eki":["320420094"],"issn":["1532-1827"],"zdb":["2002452-6"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"name":{"displayForm":["T. Elsir, M. Qu, S.G. Berntsson, A. Orrego, T. Olofsson, M.S. Lindström, M. Nistér, A. von Deimling, C. Hartmann, D. Ribom and A. Smits"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"10 May 2011"}]} 
SRT |a ELSIRTAMADPROX1ISAPR1020